Report Detail

Pharma & Healthcare Global Panitumumab Market Growth (Status and Outlook) 2019-2024

  • RnM3134439
  • |
  • 18 March, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).

According to this study, over the next five years the Panitumumab market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Panitumumab business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Panitumumab market by product type, application, key companies and key regions.

This study considers the Panitumumab value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Panitumumab market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Panitumumab market by identifying its various subsegments.
Focuses on the key global Panitumumab players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Panitumumab with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Panitumumab submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Panitumumab Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Panitumumab Market Size 2014-2024
        • 2.1.2 Panitumumab Market Size CAGR by Region
      • 2.2 Panitumumab Segment by Type
        • 2.2.1 100 mg/5 mL single-dose vials
        • 2.2.2 400 mg/20 mLsingle-dose vials
      • 2.3 Panitumumab Market Size by Type
        • 2.3.1 Global Panitumumab Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Panitumumab Market Size Growth Rate by Type (2014-2019)
      • 2.4 Panitumumab Segment by Application
        • 2.4.1 Hospital
        • 2.4.2 Drug store
      • 2.5 Panitumumab Market Size by Application
        • 2.5.1 Global Panitumumab Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Panitumumab Market Size Growth Rate by Application (2014-2019)

      3 Global Panitumumab by Players

      • 3.1 Global Panitumumab Market Size Market Share by Players
        • 3.1.1 Global Panitumumab Market Size by Players (2017-2019)
        • 3.1.2 Global Panitumumab Market Size Market Share by Players (2017-2019)
      • 3.2 Global Panitumumab Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Panitumumab by Regions

      • 4.1 Panitumumab Market Size by Regions
      • 4.2 Americas Panitumumab Market Size Growth
      • 4.3 APAC Panitumumab Market Size Growth
      • 4.4 Europe Panitumumab Market Size Growth
      • 4.5 Middle East & Africa Panitumumab Market Size Growth

      5 Americas

      • 5.1 Americas Panitumumab Market Size by Countries
      • 5.2 Americas Panitumumab Market Size by Type
      • 5.3 Americas Panitumumab Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Panitumumab Market Size by Countries
      • 6.2 APAC Panitumumab Market Size by Type
      • 6.3 APAC Panitumumab Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Panitumumab by Countries
      • 7.2 Europe Panitumumab Market Size by Type
      • 7.3 Europe Panitumumab Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Panitumumab by Countries
      • 8.2 Middle East & Africa Panitumumab Market Size by Type
      • 8.3 Middle East & Africa Panitumumab Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Panitumumab Market Forecast

      • 10.1 Global Panitumumab Market Size Forecast (2019-2024)
      • 10.2 Global Panitumumab Forecast by Regions
        • 10.2.1 Global Panitumumab Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Panitumumab Forecast by Type
      • 10.8 Global Panitumumab Forecast by Application

      11 Key Players Analysis

      • 11.1 Amgen
        • 11.1.1 Company Details
        • 11.1.2 Panitumumab Product Offered
        • 11.1.3 Amgen Panitumumab Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Amgen News

      ...

        12 Research Findings and Conclusion

        Summary:
        Get latest Market Research Reports on Panitumumab . Industry analysis & Market Report on Panitumumab is a syndicated market report, published as Global Panitumumab Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Panitumumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,660.00
        $5,490.00
        $7,320.00
        2,924.34
        4,386.51
        5,848.68
        3,396.48
        5,094.72
        6,792.96
        570,447.60
        855,671.40
        1,140,895.20
        305,866.20
        458,799.30
        611,732.40
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report